Pharma CTV Creative: Length, Fair Balance, and Interactive Formats

CTV inventory was built around the needs of consumer brands, where a 15 or 30 second spot is the norm. Pharma creative has different constraints. The ad type (product claim, reminder, or help-seeking) determines what has to be on screen, and that in turn determines how long the spot needs to be. Getting this wrong is expensive, because the mismatch usually surfaces after the media is bought.

How pharma CTV creative length follows the ad type

Three ad types matter here, explained in more depth in reminder, help-seeking, and product claim ads:

• Product claim ads name the drug and what it treats. They need fair balance, a major statement of the most important risks in audio, and adequate provision for full prescribing information.
• Reminder ads name the drug but make no claim about use. They do not carry the risk information, but they are not allowed for products with a boxed warning.
• Help-seeking ads talk about a condition without naming a drug.

The media implication is the one I would raise first in planning. If the brand's only approved product claim spot is 75 seconds, a CTV plan built on 30s pods will either run a different ad or not run. Confirm spot length acceptance with every partner before the IO is signed. The linear TV vs. CTV decision article shows how this affects budget shifts.

Fair balance and the major statement on streaming

FDA's final rule on presenting the major statement in TV and radio ads in a clear, conspicuous, and neutral manner was published in 2023. Among its standards: the major statement in TV ads should be presented in both audio and on-screen text at the same time, in consumer-friendly language, without distracting audio or visuals. As of 2026, check the current text in 21 CFR 202 and with your regulatory team. Most teams treat CTV spots as TV ads under these rules, not as online video, even when the impression is bought programmatically.

A few practical points for streaming:

• On-screen text must be legible on the full range of TV screen sizes and on mobile if the OTT line includes phones. Text that reads well on a 65 inch TV can be tiny on a phone.
• Some CTV players overlay ad countdown timers or "ad 1 of 3" labels on the spot. Check that they do not cover supers.
• Closed captions matter for accessibility and are generally expected. Accessible video creative in healthcare marketing covers caption and contrast standards.
• If a publisher transcodes your file, confirm the audio levels of the major statement match the rest of the spot after transcoding.

For how fair balance works in banners and social, see fair balance in digital pharma ads.

QR codes in pharma CTV ads

QR codes let a viewer move from the TV to a phone without typing a URL. For pharma, they can point to a savings program, a doctor discussion guide, or the brand site. They raise four questions in review:

1. Timing. A QR code on screen during the major statement competes for attention with the risk information. Many teams place it before or after.
2. Destination. The landing page must carry the right safety information and, for product claim ads, easy access to prescribing information. How to evaluate a DTC pharma landing experience covers what to check.
3. Tracking. A QR scan creates a site visit tied to a household exposure. Any tracking on the landing page needs pixel governance and privacy review, because condition-level browsing is sensitive under state consumer health data laws.
4. Duration. The code needs to stay on screen long enough to scan, which takes time from a short spot.

Pause ads, interactive units, and shoppable formats

Streaming platforms sell several non-standard formats. Each fits pharma differently.

The general rule: the more a format departs from a standard spot, the earlier MLR should see a mockup in the real player environment. A static PDF of an interactive unit does not show reviewers what the viewer will see.

Getting pharma CTV creative through MLR faster

1. Confirm spot lengths and formats with media partners before creative production starts.
2. Send MLR a screen recording of the spot playing in the actual CTV player, including any overlays.
3. Submit QR code destinations and tracking plans with the creative, not after.
4. Prepare cutdowns as separate assets with their own ad type classification. A 15s reminder cut of a 60s product claim spot is a new piece for review.
5. Keep a log of which assets are approved for which formats and platforms, so trafficking cannot run the wrong version.

MLR review for programmatic media has more on reducing review cycles, and the series guide on CTV and OTT healthcare advertising places creative in the overall plan.

Practical takeaway

Build a creative matrix before the next CTV buy: every approved asset by length and ad type in rows, every CTV partner and format in columns, and a yes or no in each cell for whether the partner accepts it. Do not sign any line where the brand's intended ad type has no approved asset that fits.

Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.